FOLH1 and prostate carcinoma: For instance, capromab (7E11) is an mAb that binds to an epitope on the intracellular domain of PSMA and has been investigated as a SPECT imaging tracer for prostate cancer [12] and as a therapeutic agent when labeling with 90Y [13].